Angel Matthew, CEO & President, Director, Ten Percent Owner at Tempest Therapeutics, holds 231.48K shares in Tempest Therapeutics (Ticker: TPST), holds ― shares in Eterna Therapeutics (Ticker: ERNA). Most recently, Angel Matthew Bought ― shares of Tempest Therapeutics on Jun 23, 2026 for an estimated value of $500.00K.
What is the percentage of profitable transactions made by Angel Matthew?
The percentage of profitable transactions made by Angel Matthew is 0%.
What is the average return per transaction made by Angel Matthew?
The average return per transaction made by Angel Matthew is -30.30%.
What stocks does Angel Matthew hold?
Angel Matthew holds: TPST, ERNA stocks.
What was Angel Matthew’s latest transaction?
Angel Matthew latest transaction was an Informative Buy of $500.00K.
What was Angel Matthew's most profitable transaction?
Angel Matthew’s most profitable transaction was an Informative Buy of TPST stock on June 23, 2026. The return on the trade was -19.10%.
What is Angel Matthew's role in Tempest Therapeutics?
Angel Matthew's role in Tempest Therapeutics is CEO & President, Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.